Serocit 46.7% Injection

Serocit 46.7% Injection contains sodium citrate as its active component. This medication is used primarily for managing acidosis and as an anticoagulant in certain medical procedures. Acidosis develops when the body's pH becomes too acidic due to imbalance in acid production or elimination. Uncontrolled diabetes, kidney dysfunction, or severe dehydration can cause this condition. This medication neutralises excess acid in the blood, restoring pH balance. Serocit 46.7% Injection serves as an anticoagulant in some medical procedures, particularly when blood requires drawing or storage outside the body. It prevents blood clotting, which is essential for certain diagnostic tests and blood transfusions. A common application is in preparing blood products such as packed red blood cells or platelets for transfusion. Avoid using this medication if you have known hypersensitivity or allergy to Serocit 46.7% Injection or any of its components. It can alter electrolyte levels in the body, including sodium and potassium. Caution should be exercised in individuals with conditions that may lead to electrolyte imbalances, such as kidney problems or heart failure. Individuals with impaired kidney function should use it cautiously, as it may affect the body's capacity to maintain electrolyte balance. Patients with certain gastrointestinal disorders, such as gastric outlet obstruction or severe inflammatory bowel disease, should avoid Serocit 46.7% Injection. Special care and appropriate dosage adjustments may be required in children or elderly individuals.

Serocit 46.7% Injection is used to treat the following: Metabolic acidosis Anticoagulant for medical procedures

By administering Serocit 46.7% Injection by injection, healthcare professionals can help neutralize the excess acid, restoring the body's pH balance and alleviating symptoms associated with acidosis, such as rapid breathing, confusion, and fatigue. By inhibiting the coagulation process, this medication ensures that the blood remains in a liquid state, facilitating the success of these procedures and reducing the risk of complications related to clot formation.

To use Serocit 46.7% Injection, follow the instructions provided by your healthcare professional or as indicated on the product label. This medication is typically administered intravenously under medical supervision to treat metabolic acidosis. The dosage will be determined based on your specific condition and needs. It is added to blood products for anticoagulant purposes during medical procedures to prevent clotting.

Serocit 46.7% Injection causes some side effects like all medications, although not everyone will experience them. Serious: Allergic reactions (rash, itching, swelling, severe dizziness, difficulty breathing) Electrolyte imbalances (unusual weakness, irregular heartbeat, muscle cramps, seizures) Signs of infection at the injection site (if used intravenously) Severe abdominal pain or discomfort Signs of dehydration (excessive thirst, dry mouth, decreased urine output) Common: Nausea Vomiting Diarrhea Abdominal discomfort Bloating Excess gas (flatulence)

Advice regarding Serocit 46.7% Injection is to consult with a healthcare professional before starting or making any changes to your medication regimen. They can assess your medical history, evaluate potential risks and benefits, provide personalized guidance, and monitor your progress throughout treatment. Additionally, closely follow your healthcare provider's instructions and recommendations, promptly report any unusual or concerning symptoms, and communicate openly about any concerns or questions you may have. Precautions should be taken when using this medication in patients with liver or kidney impairment, as dosage adjustments or special monitoring may be required. Pregnant and breastfeeding individuals should consult with healthcare professionals before using this medication. Your healthcare professional is the best resource for ensuring safe and effective medication use. Special cautions are required in pediatrics and geriatrics.